USA’s Gilead CEO John Milligan to step down
Gilead Sciences, the leading biopharmaceutical company of America has announced that John Milligan, the president and chief executive officer of the company will step down after serving the company for 28 long years.
Milligan will remain in his present position by the end of the year while the company's board conducts a search for his successor. A replacement has not been done yet, however, the company’s board is looking for it.
“It has been an honor to work at Gilead for my entire professional career and, now that the company is on solid footing for the future, the Board and I have agreed it is a good time to turn the reins over to a new leader,” Milligan exclaimed. “I’m looking forward to a well-deserved break and will then move on to new and different opportunities.”
Along with thi...